ASCO shared a post on LinkedIn:
“New ASCO26 research from Claudia Marchetti, MD, of the Fondazione Policlinico Universitario Agostino Gemelli IRCCS in Rome found that fasting before and after chemotherapy sessions, when compared with regular eating, can help reduce insulin levels and may improve treatment response for people with high-grade serous ovarian cancer (HGSOC).
Dr. Eleonora Teplinsky, MD, FASCO, breaks down what this new research means in our latest Science in Seconds.”
Title: Effects of short-term fasting compared to free diet in ovarian cancer patients: Results from a two-arm pilot randomized trial.
Author: Claudia Marchetti
Other articles about ASCO on OncoDaily.